SkyePharma revenues up on Flutiform roll-out
This article was originally published in Scrip
Executive Summary
UK drug delivery specialist SkyePharma has posted a good set of first half results on the back of the continued roll-out of Flutiform in Europe. Revenues were up 58% at £31.3m (H1 2012: £19.8m).